Reduced vascular NO bioavailability in diabetes increases platelet activation in vivo

Arteriosclerosis, Thrombosis, and Vascular Biology
Andreas SchäferKeith M Channon

Abstract

Platelet activation is a feature of cardiovascular disease that is also characterized by endothelial dysfunction. The direct relationship between impaired endothelium-derived NO bioavailability and platelet activation remains unclear. We investigated whether acute inhibition of NO production modulates platelet activation in mice and whether specific rescue of endothelial function in diabetes modifies platelet activation. Intravenous injection of the NO synthase inhibitor N(G)-nitro-L-arginine methyl ester in wild-type (WT) mice significantly reduced platelet vasodilator-stimulated phosphoprotein (VASP) phosphorylation and increased platelet surface expression of P-selectin, CD40 ligand, and fibrinogen platelet binding, demonstrating that NO production exerts tonic inhibition of platelet activation in mice. Diabetes was induced by streptozotocin injection in WT or endothelial-targeted guanosine 5'-triphosphate cyclohydrolase I (GCH)-transgenic (GCH-Tg) mice protected from endothelial dysfunction in diabetes by sustained levels of tetrahydrobiopterin in vascular endothelium. Platelet VASP phosphorylation was significantly reduced in diabetic WT but not in diabetic GCH-Tg mice. P-selectin, CD40 ligand expression, and fibrinogen bi...Continue Reading

References

Oct 1, 1992·Diabetes·P D Winocour
Jan 1, 1993·Seminars in Thrombosis and Hemostasis·D TschoepeF A Gries
Mar 12, 1999·Journal of Molecular and Cellular Cardiology·I Fleming, R Busse
Apr 20, 1999·The Journal of Experimental Medicine·S MassbergF Hofmann
Jul 8, 1999·Proceedings of the National Academy of Sciences of the United States of America·W HauserM Zimmer
Feb 17, 2000·Journal of the American College of Cardiology·M ShechterS Kaul
Feb 24, 2001·Journal of the American College of Cardiology·N P AndrewsA A Quyyumi
Mar 15, 2001·American Journal of Physiology. Heart and Circulatory Physiology·Y LiR Bose
Nov 14, 2001·Biochemical Pharmacology·U R SchwarzM Eigenthaler
Feb 28, 2002·The Journal of Pharmacology and Experimental Therapeutics·Jochen GraffCarl M Kirchmaier
Mar 5, 2002·Nature Medicine·Patrick AndréDenisa D Wagner
Oct 9, 2002·The Journal of Experimental Medicine·Steffen MassbergMeinrad Gawaz
Mar 21, 2003·The New England Journal of Medicine·Christopher HeeschenUNKNOWN CAPTURE Study Investigators
Jul 23, 2003·Journal of Thrombosis and Haemostasis : JTH·J E Freedman, J Loscalzo
Aug 30, 2003·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Didier KehHerwig Gerlach
Apr 7, 2004·Circulation·Andreas SchäferKeith M Channon

❮ Previous
Next ❯

Citations

Mar 20, 2010·Pflügers Archiv : European journal of physiology·Hong Ding, Chris R Triggle
Feb 4, 2010·Clinical and Experimental Medicine·Jinchuan YanGuanghua Chen
Mar 23, 2005·Current Opinion in Pharmacology·Burton E Sobel, David J Schneider
Jul 5, 2011·American Journal of Physiology. Heart and Circulatory Physiology·Kanchana KaruppiahArturo J Cardounel
Oct 26, 2012·Journal of Geriatric Cardiology : JGC·Graziano Riccioni, Valeriana Sblendorio
Dec 18, 2013·Thrombosis and Haemostasis·Steven K HildemannAndreas Schäfer
May 25, 2013·Thrombosis and Haemostasis·Emanuela FalcinelliPaolo Gresele
Aug 27, 2011·The Biochemical Journal·Ernst R WernerBeat Thöny
Feb 7, 2018·Frontiers in Cardiovascular Medicine·Nikoletta Pechlivani, Ramzi A Ajjan
Oct 7, 2006·Arteriosclerosis, Thrombosis, and Vascular Biology·Andreas SchäferJohann Bauersachs
Mar 12, 2005·Arteriosclerosis, Thrombosis, and Vascular Biology·Andreas SchäferJohann Bauersachs
Apr 9, 2010·Microcirculation : the Official Journal of the Microcirculatory Society, Inc·D Neil GrangerElena Y Senchenkova
Feb 28, 2019·International Journal of Experimental Pathology·Tomasz PrzygodzkiCezary Watala
Mar 21, 2009·British Journal of Haematology·Gianfranco LessianiGiovanni Davì
May 6, 2011·American Journal of Hematology·Erfan NurUNKNOWN CURAMA Study Group
Feb 14, 2013·Microcirculation : the Official Journal of the Microcirculatory Society, Inc·Dan SecorKarel Tyml
Sep 2, 2020·Cancer Metastasis Reviews·Alessandra V S FariaGwenny M Fuhler
Jul 13, 2006·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Denise M RayRichard P Phipps
Mar 31, 2012·International Journal of Experimental Pathology·Azadeh KhaliliShima Fakher
Sep 8, 2020·Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS·Emre GazyakanHolger Engel
Nov 23, 2007·Biophysical Journal·Xiaoping LiuAvner Friedman
Feb 12, 2008·Free Radical Biology & Medicine·Katherine C WoodMark T Gladwin
Dec 15, 2012·Diabetes Care·Denise M McDonaldGary E McVeigh

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.